SUSD1
geneOn this page
Also known as DKFZP761E1824
Summary
SUSD1 (sushi domain containing 1, HGNC:25413) is a protein-coding gene on chromosome 9q31.3-q32, encoding Sushi domain-containing protein 1 (Q6UWL2).
Predicted to enable calcium ion binding activity. Predicted to be located in membrane.
Source: NCBI Gene 64420 — RefSeq curated summary.
At a glance
- GWAS associations: 18
- Clinical variants (ClinVar): 103 total
- MANE Select transcript:
NM_022486
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25413 |
| Approved symbol | SUSD1 |
| Name | sushi domain containing 1 |
| Location | 9q31.3-q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP761E1824 |
| Ensembl gene | ENSG00000106868 |
| Ensembl biotype | protein_coding |
| Entrez | 64420 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 14 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron, 1 nonsense_mediated_decay
ENST00000355396, ENST00000374263, ENST00000374264, ENST00000374270, ENST00000415074, ENST00000475283, ENST00000482851, ENST00000528773, ENST00000529933, ENST00000532348, ENST00000861054, ENST00000861055, ENST00000861056, ENST00000861057, ENST00000861058, ENST00000861059, ENST00000931618, ENST00000960398, ENST00000960399
RefSeq mRNA: 3 — MANE Select: NM_022486
NM_001282640, NM_001282643, NM_022486
CCDS: CCDS65105, CCDS65106, CCDS6783
Canonical transcript exons
ENST00000374270 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000720713 | 112111654 | 112111840 |
| ENSE00000720729 | 112112771 | 112112868 |
| ENSE00001612781 | 112062937 | 112063033 |
| ENSE00001622103 | 112078538 | 112078724 |
| ENSE00001640205 | 112052399 | 112052438 |
| ENSE00001668205 | 112149244 | 112149399 |
| ENSE00001722205 | 112058428 | 112058686 |
| ENSE00001798540 | 112157500 | 112157613 |
| ENSE00003461061 | 112080074 | 112080165 |
| ENSE00003461995 | 112124257 | 112124436 |
| ENSE00003469860 | 112041867 | 112041960 |
| ENSE00003471387 | 112142320 | 112142499 |
| ENSE00003477703 | 112040783 | 112041492 |
| ENSE00003485577 | 112098470 | 112098662 |
| ENSE00003499719 | 112102176 | 112102285 |
| ENSE00003517129 | 112143471 | 112143623 |
| ENSE00003900695 | 112175133 | 112175297 |
Expression profiles
Bgee: expression breadth ubiquitous, 204 present calls, max score 93.92.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.3164 / max 187.9243, expressed in 1755 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 102051 | 7.5595 | 1648 |
| 102053 | 2.5853 | 1184 |
| 102050 | 1.0088 | 489 |
| 102052 | 0.9786 | 524 |
| 102055 | 0.4789 | 234 |
| 102054 | 0.2373 | 101 |
| 102049 | 0.2349 | 97 |
| 102048 | 0.1937 | 82 |
| 102047 | 0.0394 | 15 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 93.92 | gold quality |
| leukocyte | CL:0000738 | 93.59 | gold quality |
| granulocyte | CL:0000094 | 91.01 | gold quality |
| islet of Langerhans | UBERON:0000006 | 90.49 | gold quality |
| blood | UBERON:0000178 | 85.87 | gold quality |
| bone marrow cell | CL:0002092 | 84.74 | gold quality |
| adrenal tissue | UBERON:0018303 | 83.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.30 | gold quality |
| ileal mucosa | UBERON:0000331 | 82.49 | silver quality |
| metanephros cortex | UBERON:0010533 | 82.15 | gold quality |
| cortical plate | UBERON:0005343 | 81.99 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.81 | gold quality |
| ventricular zone | UBERON:0003053 | 81.79 | gold quality |
| colonic epithelium | UBERON:0000397 | 81.54 | gold quality |
| rectum | UBERON:0001052 | 81.50 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.10 | gold quality |
| vermiform appendix | UBERON:0001154 | 81.05 | gold quality |
| decidua | UBERON:0002450 | 80.86 | gold quality |
| placenta | UBERON:0001987 | 80.60 | gold quality |
| right adrenal gland | UBERON:0001233 | 80.54 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 80.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 80.44 | gold quality |
| adrenal gland | UBERON:0002369 | 79.95 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 79.88 | gold quality |
| left adrenal gland | UBERON:0001234 | 79.81 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 79.69 | gold quality |
| upper lobe of lung | UBERON:0008948 | 79.58 | gold quality |
| gall bladder | UBERON:0002110 | 79.53 | gold quality |
| lymph node | UBERON:0000029 | 79.35 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 79.34 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 1125.45 |
| E-ANND-3 | yes | 5.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting SUSD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-106B-5P | 99.88 | 74.72 | 2795 |
| HSA-MIR-20A-5P | 99.88 | 74.76 | 2769 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-526B-3P | 99.88 | 74.06 | 2587 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-372-3P | 99.83 | 70.58 | 1691 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-1200 | 99.71 | 70.42 | 1838 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-452-5P | 99.65 | 69.63 | 1762 |
| HSA-MIR-4676-3P | 99.65 | 69.31 | 1733 |
| HSA-MIR-892C-3P | 99.65 | 69.38 | 1745 |
| HSA-MIR-217-5P | 99.49 | 69.93 | 1419 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | susd1 | ENSDARG00000058839 |
| mus_musculus | Susd1 | ENSMUSG00000038578 |
| rattus_norvegicus | Susd1 | ENSRNOG00000056819 |
Protein
Protein identifiers
Sushi domain-containing protein 1 — Q6UWL2 (reviewed: Q6UWL2)
All UniProt accessions (5): Q6UWL2, F8WAQ1, H0Y6B2, H0YCH6, H3BLV4
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6UWL2-1 | 1 | yes |
| Q6UWL2-2 | 2 | |
| Q6UWL2-3 | 3 |
RefSeq proteins (3): NP_001269569, NP_001269572, NP_071931* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000152 | EGF-type_Asp/Asn_hydroxyl_site | PTM |
| IPR000436 | Sushi_SCR_CCP_dom | Domain |
| IPR000742 | EGF | Domain |
| IPR001881 | EGF-like_Ca-bd_dom | Domain |
| IPR009030 | Growth_fac_rcpt_cys_sf | Homologous_superfamily |
| IPR018097 | EGF_Ca-bd_CS | Conserved_site |
| IPR035976 | Sushi/SCR/CCP_sf | Homologous_superfamily |
| IPR049883 | NOTCH1_EGF-like | Domain |
| IPR051622 | R-tyr_protein_phosphatases | Family |
| IPR057598 | Fn3_PTPRU | Domain |
Pfam: PF00084, PF07645, PF23144
UniProt features (32 total): disulfide bond 11, glycosylation site 7, domain 5, topological domain 2, splice variant 2, sequence variant 2, signal peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6UWL2-F1 | 78.21 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (11): 39–48, 42–57, 59–71, 77–91, 85–100, 129–141, 135–150, 179–221, 206–234, 239–281, 266–294
Glycosylation sites (7): 87, 112, 193, 253, 348, 367, 563
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 135 (showing top):
GSE45365_NK_CELL_VS_BCELL_DN, SRF_Q5_01, SRF_01, SRF_C, GATA3_01, GATA1_02, GATA_Q6, SCGGAAGY_ELK1_02, KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3, PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7, KRIEG_HYPOXIA_NOT_VIA_KDM3A, RREB1_01, CSHL1_TARGET_GENES, HES2_TARGET_GENES, PAX3_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): calcium ion binding (GO:0005509)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
592 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SUSD1 | VMA22 | Q96NT0 | 518 |
| SUSD1 | SUSD2 | Q9UGT4 | 511 |
| SUSD1 | SLC46A2 | Q9BY10 | 507 |
| SUSD1 | CAPN9 | O14815 | 500 |
| SUSD1 | NIPSNAP3B | Q9BS92 | 494 |
| SUSD1 | CYP2F1 | P24903 | 486 |
| SUSD1 | GARIN6 | Q8NEG0 | 479 |
| SUSD1 | TBC1D9B | Q66K14 | 460 |
| SUSD1 | CNKSR2 | Q8WXI2 | 460 |
| SUSD1 | ATP6V1G2 | O95670 | 458 |
| SUSD1 | AP5M1 | Q9H0R1 | 457 |
| SUSD1 | PARM1 | Q6UWI2 | 456 |
| SUSD1 | TDRD3 | Q9H7E2 | 450 |
| SUSD1 | SPG11 | Q96JI7 | 444 |
| SUSD1 | CHFR | Q96EP1 | 443 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EGFR | CTNND1 | psi-mi:“MI:0914”(association) | 0.750 |
| SCGB1D1 | FAM234B | psi-mi:“MI:0914”(association) | 0.530 |
| FBXO2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.530 |
| DEFA1 | MANBA | psi-mi:“MI:0914”(association) | 0.530 |
| B4GAT1 | ADCY6 | psi-mi:“MI:0914”(association) | 0.530 |
| INSL5 | COCH | psi-mi:“MI:0914”(association) | 0.530 |
| DIPK1A | TMEM259 | psi-mi:“MI:0914”(association) | 0.530 |
| SUSD1 | ATF7IP | psi-mi:“MI:0915”(physical association) | 0.370 |
| TMEM106A | QSOX1 | psi-mi:“MI:0914”(association) | 0.350 |
| CLEC2D | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| ST8SIA4 | FAM234B | psi-mi:“MI:0914”(association) | 0.350 |
| MPPE1 | FAM234B | psi-mi:“MI:0914”(association) | 0.350 |
| RNASE13 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| PSCA | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| CRLF2 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| RLN1 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| SCGB2A2 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| GPIHBP1 | SAC3D1 | psi-mi:“MI:0914”(association) | 0.350 |
| CST9L | QSOX1 | psi-mi:“MI:0914”(association) | 0.350 |
| CCL19 | DCTN6 | psi-mi:“MI:0914”(association) | 0.350 |
| PATE1 | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| C1QA | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| PTPRK | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB135 | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB107A | ZZEF1 | psi-mi:“MI:0914”(association) | 0.350 |
| G0S2 | OIP5 | psi-mi:“MI:0914”(association) | 0.350 |
| DNAJC25-GNG10 | CHST10 | psi-mi:“MI:0914”(association) | 0.350 |
| CD1A | EXTL3 | psi-mi:“MI:0914”(association) | 0.350 |
| EDDM3A | PLXNA2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (48): SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-MS), SUSD1 (Affinity Capture-RNA), SUSD1 (Affinity Capture-MS)
ESM2 similar proteins: A0JNA2, A4FUY1, C0HL12, O14514, O19131, O60241, O75325, P0C5H6, P15151, P32506, P32507, P70225, P98095, Q05BQ1, Q13477, Q14626, Q14CZ8, Q29RN8, Q3UHD1, Q4V9Z5, Q53EL9, Q5DRQ8, Q5R7Y0, Q5RF19, Q5STE3, Q63148, Q64385, Q6AX42, Q6BAA4, Q6MZW2, Q6UWL2, Q6UWL6, Q6UXD5, Q6WN34, Q7TSK2, Q7TSU7, Q8BHA1, Q8BQC3, Q8CGM1, Q8IVU1
Diamond homologs: A0A1D5NSM8, A2AVA0, D3YXF5, O02839, O19124, O35764, O43405, O62685, O62837, O70340, O76536, O95502, O96530, P00751, P04003, P04186, P06205, P06206, P06207, P06681, P07629, P08174, P08607, P0C6B8, P13944, P14151, P14650, P15529, P17690, P18337, P26022, P32018, P33703, P35419, P42201, P47970, P47971, P47972, P48199, P48759
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
103 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 85 |
| Likely benign | 12 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3953 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:112041866:CCACA:C | donor_gain | 1.0000 |
| 9:112058473:C:CA | donor_gain | 1.0000 |
| 9:112063041:CATGT:C | acceptor_gain | 1.0000 |
| 9:112063042:A:C | acceptor_gain | 1.0000 |
| 9:112063045:T:TC | acceptor_gain | 1.0000 |
| 9:112080072:A:AC | donor_gain | 1.0000 |
| 9:112080073:C:CT | donor_gain | 1.0000 |
| 9:112080073:CT:C | donor_gain | 1.0000 |
| 9:112080161:TTTTA:T | acceptor_gain | 1.0000 |
| 9:112080162:TTTA:T | acceptor_gain | 1.0000 |
| 9:112080163:TTA:T | acceptor_gain | 1.0000 |
| 9:112080164:TA:T | acceptor_gain | 1.0000 |
| 9:112080165:ACTG:A | acceptor_loss | 1.0000 |
| 9:112080166:C:CC | acceptor_gain | 1.0000 |
| 9:112080166:CT:C | acceptor_loss | 1.0000 |
| 9:112080168:G:C | acceptor_gain | 1.0000 |
| 9:112080171:G:GC | acceptor_gain | 1.0000 |
| 9:112098663:C:CC | acceptor_gain | 1.0000 |
| 9:112102174:A:AC | donor_gain | 1.0000 |
| 9:112102175:C:CC | donor_gain | 1.0000 |
| 9:112102283:CTT:C | acceptor_gain | 1.0000 |
| 9:112109313:T:TA | donor_gain | 1.0000 |
| 9:112109314:C:A | donor_gain | 1.0000 |
| 9:112111649:CCTA:C | donor_loss | 1.0000 |
| 9:112111651:TA:T | donor_loss | 1.0000 |
| 9:112111652:A:AC | donor_gain | 1.0000 |
| 9:112111652:ACCA:A | donor_loss | 1.0000 |
| 9:112111653:C:CA | donor_loss | 1.0000 |
| 9:112111653:C:CC | donor_gain | 1.0000 |
| 9:112111653:CCAG:C | donor_gain | 1.0000 |
AlphaMissense
4866 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:112149387:C:G | C77S | 0.995 |
| 9:112149388:A:T | C77S | 0.995 |
| 9:112157505:C:G | C71S | 0.995 |
| 9:112157506:A:T | C71S | 0.995 |
| 9:112142345:C:A | W227C | 0.994 |
| 9:112142345:C:G | W227C | 0.994 |
| 9:112149363:C:G | C85S | 0.994 |
| 9:112149364:A:T | C85S | 0.994 |
| 9:112149345:C:G | C91S | 0.993 |
| 9:112149346:A:T | C91S | 0.993 |
| 9:112149249:C:G | C123S | 0.992 |
| 9:112149250:A:T | C123S | 0.992 |
| 9:112149273:A:C | F115C | 0.992 |
| 9:112149323:G:C | F98L | 0.992 |
| 9:112149323:G:T | F98L | 0.992 |
| 9:112149325:A:G | F98L | 0.992 |
| 9:112157528:A:C | F63L | 0.992 |
| 9:112157528:A:T | F63L | 0.992 |
| 9:112157530:A:G | F63L | 0.992 |
| 9:112149272:G:C | F115L | 0.991 |
| 9:112149272:G:T | F115L | 0.991 |
| 9:112149274:A:G | F115L | 0.991 |
| 9:112149317:G:C | C100W | 0.991 |
| 9:112157541:C:G | C59S | 0.991 |
| 9:112157542:A:T | C59S | 0.991 |
| 9:112149363:C:T | C85Y | 0.990 |
| 9:112157541:C:T | C59Y | 0.990 |
| 9:112149249:C:T | C123Y | 0.989 |
| 9:112149311:G:C | C102W | 0.989 |
| 9:112157506:A:G | C71R | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000013592 (9:112094256 T>C), RS1000039010 (9:112157653 A>T), RS1000093212 (9:112043903 C>T), RS1000096938 (9:112131940 G>A), RS1000099032 (9:112118390 T>C), RS1000184435 (9:112071080 A>G), RS1000190941 (9:112108089 G>GA), RS1000251132 (9:112125894 G>A), RS1000289949 (9:112169076 G>A), RS1000307152 (9:112100258 C>A), RS1000321377 (9:112080979 A>G), RS1000351545 (9:112081717 G>A), RS1000358854 (9:112099184 A>T), RS1000365839 (9:112057318 A>T), RS1000383411 (9:112099013 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
18 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000013_6 | Amyotrophic lateral sclerosis | 6.000000e-06 |
| GCST001762_83 | Obesity-related traits | 4.000000e-06 |
| GCST002012_6 | Venous thromboembolism | 3.000000e-06 |
| GCST007354_6 | Intracranial aneurysm | 1.000000e-08 |
| GCST008462_6 | Plasma factor V levels in venous thrombosis (conditioned on rs6027) | 6.000000e-06 |
| GCST009525_3 | Panic disorder | 3.000000e-06 |
| GCST010083_1 | Hemoglobin levels | 1.000000e-13 |
| GCST90002383_520 | Hematocrit | 1.000000e-09 |
| GCST90002383_521 | Hematocrit | 1.000000e-10 |
| GCST90002384_264 | Hemoglobin | 4.000000e-10 |
| GCST90002384_265 | Hemoglobin | 4.000000e-12 |
| GCST90002390_396 | Mean corpuscular hemoglobin | 4.000000e-14 |
| GCST90002392_543 | Mean corpuscular volume | 3.000000e-09 |
| GCST90002403_616 | Red blood cell count | 4.000000e-12 |
| GCST90002404_120 | Red cell distribution width | 8.000000e-15 |
| GCST90002405_467 | Reticulocyte count | 1.000000e-11 |
| GCST90002405_468 | Reticulocyte count | 9.000000e-11 |
| GCST90002406_283 | Reticulocyte fraction of red cells | 1.000000e-12 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003940 | physical activity |
| EFO:0004509 | hemoglobin measurement |
| EFO:0004348 | hematocrit |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004305 | erythrocyte count |
| EFO:0009188 | Red cell distribution width |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| nickel sulfate | decreases expression | 1 |
| K 7174 | increases expression | 1 |
| belinostat | decreases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Catechin | decreases expression, affects cotreatment | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Dexamethasone | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Sodium Dodecyl Sulfate | increases expression | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Vanadates | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): brain aneurysm, panic disorder